Blood and immune development in human fetal bone marrow and Down syndrome.


Journal

Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462

Informations de publication

Date de publication:
10 2021
Historique:
received: 30 07 2020
accepted: 18 08 2021
pubmed: 1 10 2021
medline: 19 11 2021
entrez: 30 9 2021
Statut: ppublish

Résumé

Haematopoiesis in the bone marrow (BM) maintains blood and immune cell production throughout postnatal life. Haematopoiesis first emerges in human BM at 11-12 weeks after conception

Identifiants

pubmed: 34588693
doi: 10.1038/s41586-021-03929-x
pii: 10.1038/s41586-021-03929-x
pmc: PMC7612688
mid: EMS144548
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

327-331

Subventions

Organisme : Medical Research Council
ID : MC_PC_17230
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 215116
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 216632
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 206328
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 221052
Pays : United Kingdom
Organisme : DBT-Wellcome Trust India Alliance
ID : MR/R006237/1
Pays : India
Organisme : Medical Research Council
ID : MR/M008975/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 206194
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/S036113/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : WT107931/Z/15/Z
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 107630
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N005872/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : WT206194
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 107630/Z/15/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12009/14
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/W014556/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 203151/Z/16/Z
Pays : United Kingdom
Organisme : Wellcome Trust
ID : WT211276/Z/18/Z
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 216632/Z/19/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/S036334/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 206328/Z/17/Z
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 107931
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 211276
Pays : United Kingdom

Informations de copyright

© 2021. The Author(s), under exclusive licence to Springer Nature Limited.

Références

O’Byrne, S. et al. Discovery of a CD10-negative B-progenitor in human fetal life identifies unique ontogeny-related developmental programs. Blood 134, 1059–1071 (2019).
doi: 10.1182/blood.2019001289
Charbord, P., Tavian, M., Humeau, L. & Péault, B. Early ontogeny of the human marrow from long bones: an immunohistochemical study of hematopoiesis and its microenvironment. Blood 87, 4109–4119 (1996).
doi: 10.1182/blood.V87.10.4109.bloodjournal87104109
Park, J.-E. et al. A cell atlas of human thymic development defines T cell repertoire formation. Science 367, eaay3224 (2020).
doi: 10.1126/science.aay3224
Popescu, D.-M. et al. Decoding human fetal liver haematopoiesis. Nature 574, 365–371 (2019).
doi: 10.1038/s41586-019-1652-y
Wiemels, J. L. et al. Prenatal origin of acute lymphoblastic leukaemia in children. Lancet 354, 1499–1503 (1999).
doi: 10.1016/S0140-6736(99)09403-9
Muntean, A. G., Ge, Y., Taub, J. W. & Crispino, J. D. Transcription factor GATA-1 and Down syndrome leukemogenesis. Leuk. Lymphoma 47, 986–997 (2006).
doi: 10.1080/10428190500485810
Roy, A. et al. Perturbation of fetal liver hematopoietic stem and progenitor cell development by trisomy 21. Proc. Natl Acad. Sci. USA 109, 17579–17584 (2012).
doi: 10.1073/pnas.1211405109
Olsson, A. et al. Single-cell analysis of mixed-lineage states leading to a binary cell fate choice. Exp. Hematol. 44, S24 (2016).
doi: 10.1016/j.exphem.2016.06.010
Dahl, R. et al. Regulation of macrophage and neutrophil cell fates by the PU.1:C/EBPα ratio and granulocyte colony-stimulating factor. Nat. Immunol. 4, 1029–1036 (2003).
doi: 10.1038/ni973
Villani, A.-C. et al. Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors. Science 356, eaah4573 (2017).
doi: 10.1126/science.aah4573
Mullighan, C. G. et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature 446, 758–764 (2007).
doi: 10.1038/nature05690
Summers, Y. J., Heyworth, C. M., de Wynter, E. A., Chang, J. & Testa, N. G. Cord blood G
doi: 10.1634/stemcells.19-6-505
Pimanda, J. E. et al. Gata2, Fli1, and Scl form a recursively wired gene-regulatory circuit during early hematopoietic development. Proc. Natl Acad. Sci. USA 104, 17692–17697 (2007).
doi: 10.1073/pnas.0707045104
Iwasaki, H. et al. Distinctive and indispensable roles of PU.1 in maintenance of hematopoietic stem cells and their differentiation. Blood 106, 1590–1600 (2005).
doi: 10.1182/blood-2005-03-0860
Palii, C. G. et al. Single-cell proteomics reveal that quantitative changes in co-expressed lineage-specific transcription factors determine cell fate. Cell Stem Cell 24, 812–820 (2019).
doi: 10.1016/j.stem.2019.02.006
Muskens, I. S. et al. The genome-wide impact of trisomy 21 on DNA methylation and its implications for hematopoiesis. Nat. Commun. 12, 821 (2021).
doi: 10.1038/s41467-021-21064-z
Yu, S. et al. GABP controls a critical transcription regulatory module that is essential for maintenance and differentiation of hematopoietic stem/progenitor cells. Blood 117, 2166–2178 (2011).
doi: 10.1182/blood-2010-09-306563
Sullivan, K. D. et al. Trisomy 21 causes changes in the circulating proteome indicative of chronic autoinflammation. Sci. Rep. 7, 14818 (2017).
doi: 10.1038/s41598-017-13858-3
Baccin, C. et al. Combined single-cell and spatial transcriptomics reveal the molecular, cellular and spatial bone marrow niche organization. Nat. Cell Biol. 22, 38–48 (2020).
doi: 10.1038/s41556-019-0439-6
Suchting, S. et al. The Notch ligand Delta-like 4 negatively regulates endothelial tip cell formation and vessel branching. Proc. Natl Acad. Sci. USA 104, 3225–3230 (2007).
doi: 10.1073/pnas.0611177104
Kusumbe, A. P., Ramasamy, S. K. & Adams, R. H. Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone. Nature 507, 323–328 (2014).
doi: 10.1038/nature13145
Itkin, T. et al. Distinct bone marrow blood vessels differentially regulate haematopoiesis. Nature 532, 323–328 (2016).
doi: 10.1038/nature17624
Long, M. W., Briddell, R., Walter, A. W., Bruno, E. & Hoffman, R. Human hematopoietic stem cell adherence to cytokines and matrix molecules. J. Clin. Invest. 90, 251–255 (1992).
doi: 10.1172/JCI115844
Lane, W. J. et al. Stromal-derived factor 1–induced megakaryocyte migration and platelet production is dependent on matrix metalloproteinases. Blood 96, 4152–4159 (2000).
doi: 10.1182/blood.V96.13.4152
Schulz-Knappe, P. et al. HCC-1, a novel chemokine from human plasma. J. Exp. Med. 183, 295–299 (1996).
doi: 10.1084/jem.183.1.295
Butko, E., Pouget, C. & Traver, D. Complex regulation of HSC emergence by the Notch signaling pathway. Dev. Biol. 409, 129–138 (2016).
doi: 10.1016/j.ydbio.2015.11.008
Mulè, M. P., Martins, A. J. & Tsang, J. S. Normalizing and denoising protein expression data from droplet-based single cell profiling. Preprint at https://doi.org/10.1101/2020.02.24.96360 (2021).

Auteurs

Laura Jardine (L)

Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.
Haematology Department, Freeman Hospital, Newcastle-upon-Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.

Simone Webb (S)

Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.

Issac Goh (I)

Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.

Mariana Quiroga Londoño (M)

Department of Haematology, Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.

Gary Reynolds (G)

Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.

Michael Mather (M)

Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.

Bayanne Olabi (B)

Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.

Emily Stephenson (E)

Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.

Rachel A Botting (RA)

Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.

Dave Horsfall (D)

Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.

Justin Engelbert (J)

Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.

Daniel Maunder (D)

Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.

Nicole Mende (N)

Department of Haematology, Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.

Caitlin Murnane (C)

Department of Paediatrics, University of Oxford, Oxford, UK.

Emma Dann (E)

Wellcome Sanger Institute, Hinxton, UK.

Jim McGrath (J)

Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.

Hamish King (H)

Centre for Immunobiology, Blizard Institute, Queen Mary University of London, London, UK.

Iwo Kucinski (I)

Department of Haematology, Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.

Rachel Queen (R)

Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.

Christopher D Carey (CD)

Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.

Caroline Shrubsole (C)

Haematology Department, Freeman Hospital, Newcastle-upon-Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.

Elizabeth Poyner (E)

Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.

Meghan Acres (M)

Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.

Claire Jones (C)

NovoPath, Department of Pathology, Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.

Thomas Ness (T)

NovoPath, Department of Pathology, Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.

Rowen Coulthard (R)

NovoPath, Department of Pathology, Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.

Natalina Elliott (N)

Department of Paediatrics, University of Oxford, Oxford, UK.

Sorcha O'Byrne (S)

Department of Paediatrics, University of Oxford, Oxford, UK.

Myriam L R Haltalli (MLR)

Department of Haematology, Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.

John E Lawrence (JE)

Wellcome Sanger Institute, Hinxton, UK.

Steven Lisgo (S)

Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.

Petra Balogh (P)

Wellcome Sanger Institute, Hinxton, UK.

Kerstin B Meyer (KB)

Wellcome Sanger Institute, Hinxton, UK.

Elena Prigmore (E)

Wellcome Sanger Institute, Hinxton, UK.

Kirsty Ambridge (K)

Wellcome Sanger Institute, Hinxton, UK.

Mika Sarkin Jain (MS)

Wellcome Sanger Institute, Hinxton, UK.

Mirjana Efremova (M)

Barts Cancer Institute, Queen Mary University of London, London, UK.

Keir Pickard (K)

Haematology Department, Freeman Hospital, Newcastle-upon-Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.

Thomas Creasey (T)

Haematology Department, Freeman Hospital, Newcastle-upon-Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
Wolfson Childhood Cancer Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK.

Jaume Bacardit (J)

School of Computing, Newcastle University, Newcastle upon Tyne, UK.

Deborah Henderson (D)

Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.

Jonathan Coxhead (J)

Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.

Andrew Filby (A)

Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.

Rafiqul Hussain (R)

Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.

David Dixon (D)

Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.

David McDonald (D)

Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.

Dorin-Mirel Popescu (DM)

Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.

Monika S Kowalczyk (MS)

Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, USA.

Bo Li (B)

Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, USA.

Orr Ashenberg (O)

Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, USA.
Genentech, South San Francisco, CA, USA.

Marcin Tabaka (M)

Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, USA.

Danielle Dionne (D)

Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, USA.

Timothy L Tickle (TL)

Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, USA.
Data Sciences Platform, Broad Institute of Harvard and MIT, Cambridge, MA, USA.

Michal Slyper (M)

Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, USA.

Orit Rozenblatt-Rosen (O)

Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, USA.

Aviv Regev (A)

Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, USA.

Sam Behjati (S)

Wellcome Sanger Institute, Hinxton, UK.
Department of Paediatrics, University of Cambridge, Cambridge, UK.

Elisa Laurenti (E)

Department of Haematology, Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.

Nicola K Wilson (NK)

Department of Haematology, Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.

Anindita Roy (A)

Department of Paediatrics, University of Oxford, Oxford, UK.
MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Department of Paediatrics, Children's Hospital, John Radcliffe Hospital, and MRC WIMM, University of Oxford, Oxford, UK.
BRC Blood Theme, National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, Oxford, UK.

Berthold Göttgens (B)

Department of Haematology, Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.

Irene Roberts (I)

Department of Paediatrics, University of Oxford, Oxford, UK.
MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Department of Paediatrics, Children's Hospital, John Radcliffe Hospital, and MRC WIMM, University of Oxford, Oxford, UK.
BRC Blood Theme, National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, Oxford, UK.

Sarah A Teichmann (SA)

Wellcome Sanger Institute, Hinxton, UK.
Theory of Condensed Matter Group, Cavendish Laboratory, University of Cambridge, Cambridge, UK.

Muzlifah Haniffa (M)

Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK. m.a.haniffa@ncl.ac.uk.
Wellcome Sanger Institute, Hinxton, UK. m.a.haniffa@ncl.ac.uk.
Department of Dermatology and NIHR Newcastle Biomedical Research Centre, Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK. m.a.haniffa@ncl.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH